Side-by-side
Pick up to 3 peptides and see their key facts side by side. Useful for narrowing a search before deciding which page to read in full.
1 of 3 selected.
| Field | Last updated |
|---|---|
| Aliases | Delta sleep-inducing peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, CAS 62568-57-4 |
| Category | Mood & Stress |
| Formula | C₃₅H₄₈N₁₀O₁₅ |
| Molecular weight | 848.83 Da |
| Half-life | ~7 min |
| Mechanism (summary) | Delta sleep-inducing peptide (DSIP) is a nonapeptide first described in the 1970s with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Reviews still describe it as "a still unresolved riddle": the endogenous precursor is unknown, the receptor system is undefined, and the physiological role is incompletely established despite decades of work. |
| Dosing notes | The most concrete retrieved human dose is 25 nmol/kg IV administered in the afternoon before three monitored sleep nights in chronic insomnia. Older publications describe repeated injections over 4 to 10 administrations, but accessible abstracts do not provide a universally accepted human regimen. Modern safety margins are unspecified. |
| Storage | Phoenix Pharmaceuticals lists DSIP as soluble in water and recommends storage up to 6 months lyophilized at 0–5 °C. After rehydration: up to 5 days at 4 °C or up to 3 months at -20 °C, with aliquoting to avoid repeated freeze-thaw cycles. Supplier guidance, not a peer-reviewed stability study. |
|---|
| Read more | Full reference → |
|---|